Collaboration with external partners is a fundamental part of the innovation strategy in our Animal Health business. Learn more about the partners we are looking for.
Megan Grether, Global Head of BD&L for Animal Health, spoke to S&P Global Senior Analyst, Sian Lazell in a recent interview about the external innovation pool, what she's looking for in external partners and the challenges faced by pharma R&D teams.
Hear from our partnering team as they talk about our team culture, why collaboration is so important in advancing innovation, and what they’re looking for in their areas of focus.
Partnering in Cardiovascular, Renal and Metabolic Diseases
Our commitment to collaboration with science-driven partners and academia is driven by our ambition to help change the future for people living with cardiovascular, renal and metabolic diseases
Our Partners: Warren Center for Neuroscience Drug Discovery at Vanderbilt University
Craig Lindsley, Director of the WCNDD talks about the challenges facing neuroscience researchers and the commitment of Boehringer Ingelheim to this important area.